Compare GWH & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GWH | ADVB |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.6M |
| IPO Year | 2020 | 2023 |
| Metric | GWH | ADVB |
|---|---|---|
| Price | $0.19 | $6.75 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.25 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 65.2K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.71 | N/A |
| EPS | N/A | ★ 5.21 |
| Revenue | ★ $1,583,000.00 | N/A |
| Revenue This Year | $33.99 | N/A |
| Revenue Next Year | $1,328.57 | N/A |
| P/E Ratio | ★ N/A | $1.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.17 | $0.19 |
| 52 Week High | $13.87 | $24.23 |
| Indicator | GWH | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 26.68 | 40.05 |
| Support Level | N/A | $6.17 |
| Resistance Level | $0.42 | $7.64 |
| Average True Range (ATR) | 0.04 | 0.61 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 7.23 | 14.87 |
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. It develops and manufactures long-duration energy storage systems based on iron flow battery technology. The company's batteries use earth-abundant materials, including iron, salt, and water, and are designed for high cycle life and recyclability. It operates as a single business operating segment, which includes all activities related to the design, engineering, and manufacturing of the company's long duration energy storage products. The company's revenue is derived from the sale of its energy storage products and from service contracts.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.